Sergio Traversa - 31 Dec 2022 Form 5/A - Amendment Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
CEO, Director
Signature
/s/ Sergio Traversa
Issuer symbol
RLMD
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
5/A - Amendment
Filing time
06 Feb 2023, 16:39:14 UTC
Date Of Original Report
02 Feb 2023
Previous filing
20 Dec 2022
Next filing
30 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Gift $0 -4,131 -100% $0.000000* 0 08 Jul 2021 Common Stock 4,131 $16.00 Direct F1, F2
transaction RLMD Stock Option (right to buy) Gift $0 -27,123 -81% $0.000000 6,165 08 Jul 2021 Common Stock 27,123 $16.00 Direct F1, F3
transaction RLMD Stock Option (right to buy) Gift $0 -8,231 -73% $0.000000 3,019 08 Jul 2021 Common Stock 8,231 $54.00 Direct F1, F4
transaction RLMD Stock Option (right to buy) Gift $0 -131,250 -38% $0.000000 218,750 08 Jul 2021 Common Stock 131,250 $43.47 Direct F1, F5
transaction RLMD Stock Option (right to buy) Gift $0 -31,250 -12% $0.000000 225,000 08 Jul 2021 Common Stock 31,250 $33.43 Direct F1, F6
transaction RLMD Stock Option (right to buy) Gift $0 -62,500 -28% $0.000000 162,500 28 Sep 2022 Common Stock 62,500 $33.43 Direct F1, F6
transaction RLMD Stock Option (right to buy) Gift $0 -87,500 -35% $0.000000 162,500 28 Sep 2022 Common Stock 87,500 $33.43 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a bona fide gift of stock options to a family trust. An independent trustee is trustee of the trust.
F2 The options were granted on July 10, 2012. 25% of the options vested upon the grant date and the remaining 75% of the options vested in equal quarterly increments over the next four (4) years, so that the last set of options vested in July 2016.
F3 The options were granted on September 30, 2013. 25% of the options vested upon the date of grant and the remaining 75% of the options vested in equal quarterly increments over the next four (4) years, so that the last set of options vested in September 2017.
F4 The options were granted on February 15, 2015. 6.25% of the options vested each quarter from the date of grant.
F5 The options were granted on December 19, 2019. 6.25% of the options vest each quarter from the date of grant.
F6 The options were granted on January 7, 2021. 6.25% of the options vest each quarter from the date of grant.
F7 The options were granted on January 7, 2021. 25% of the options vested one year from the grant date, and thereafter in equal quarterly increments of 6.25% over the following three years.